Significant Ownership of Ansbert Gadicke
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ansbert Gadicke focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Boston, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Ansbert Gadicke and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Ansbert Gadicke
Significant Ownership of Ansbert Gadicke
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTSQ | AKTIS ONCOLOGY, INC. | Common Stock | 19% | $102,601 | 10,260,064 | ANSBERT GADICKE | 12 Jan 2026 | ||
| ITOS | ITEOS THERAPEUTICS, INC. | Common Stock | 4.7% | $13,259,371 | 1,803,996 | ANSBERT GADICKE | 13 May 2025 | ||
| RPTX | REPARE THERAPEUTICS INC. | Common Shares | 4.6% | $2,135,366 | -$228,990 | 1,941,242 | -9.7% | ANSBERT GADICKE | 31 Jan 2025 |
| HOWL | WEREWOLF THERAPEUTICS, INC. | Common Stock | 3.8% | $1,680,514 | -$719,307 | 1,826,646 | -30% | ANSBERT GADICKE | 08 May 2026 |
Schedules 13D/G Reported by Ansbert Gadicke:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.